FeesSafety
Pluang+

OneMedNet secures high six-figure add-on order, boosting data volume by 150% under multiyear deal

Market News
03 Nov 2026, 15:40 WIB
GlobeNewsWire
View Source
Bullish
OneMedNet secures high six-figure add-on order, boosting data volume by 150% under multiyear deal

OneMedNet Corporation received a high six-figure add-on order shortly after signing a multiyear agreement on September 30, 2026. The order expands data volume by 150% for a customer using the data to train AI models and create a derivative dataset for resale. This quick expansion highlights the value of OneMedNet's high-quality, first-party sourced Real-World Data. The company expects the partnership to grow as the customer's derivative data offering develops.

OneMedNet's recent high six-figure add-on order provides context for readers interested in healthcare data developments. For readers following the Health sector, here is Pluang's market snapshot as of Nov 03, 2026 20:11 WIB: out of 150 priced US Health-sector stocks, 75 rose and 69 fell. Notable movers include RVTY at USD 165.00 with a +8.80% change and a typical hold time of 13 days on Pluang, NBIX at USD 155.03 with a +6.66% change and 100% sell order activity, and TVTX at USD 46.23 with a -6.15% change. The most notable figure is RVTY's +8.80% one-day price increase.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
1 hour ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
1 hour ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
1 hour ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
2 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App